Corona Remedies Limited Updates CIN Following Stock Exchange Listing
Corona Remedies Limited has changed its Corporate Identification Number from U24231GJ2004PLC044656 to L24231GJ2004PLC044656 following the listing of its equity shares on BSE and NSE. The Gujarat-based pharmaceutical company, incorporated in 2004, has authorized capital of ₹61.17 crores and paid-up capital of ₹61.16 crores, maintaining active compliance status with regular corporate governance practices.
*this image is generated using AI for illustrative purposes only.
Corona Remedies Limited has announced a change in its Corporate Identification Number (CIN) following the successful listing of its equity shares on recognized stock exchanges. The pharmaceutical company informed both BSE Limited and National Stock Exchange of India Limited about this regulatory update on January 1, 2026.
CIN Modification Details
The company's CIN has been updated from U24231GJ2004PLC044656 to L24231GJ2004PLC044656, reflecting its new status as a listed entity. This change occurred pursuant to the listing of the company's equity shares on both BSE Limited and National Stock Exchange of India Limited.
| Parameter: | Details |
|---|---|
| Previous CIN: | U24231GJ2004PLC044656 |
| Updated CIN: | L24231GJ2004PLC044656 |
| Stock Exchanges: | BSE Limited & NSE Limited |
| BSE Scrip Code: | 544644 |
| NSE Script Code: | CORONA |
Company Profile and Registration
Corona Remedies Limited was incorporated on August 27, 2004, and is registered under the Registrar of Companies (ROC) Ahmedabad with registration number 044656. The company operates as a public, non-government entity limited by shares and maintains active compliance status.
The company's registered address is located at Corona House, C-Mondeal Business Park, Near Gurudwara, S. G. Highway, Thaltej, Ahmedabad, Daskroi, Gujarat, with postal code 380059.
Financial Structure
The company's capital structure demonstrates substantial financial foundation with significant authorized and paid-up capital amounts.
| Financial Metric: | Amount (₹) |
|---|---|
| Authorized Capital: | 61,17,00,880 |
| Paid-up Capital: | 61,16,00,880 |
Corporate Governance
Corona Remedies Limited maintains regular corporate governance practices with its most recent Annual General Meeting held on June 26, 2025, and balance sheet dated March 31, 2025. The company secretary and compliance officer, Chetna Dharajiya, signed the official communication regarding the CIN change.
The notification was accompanied by master data from the Ministry of Corporate Affairs website confirming the updated corporate identification details and the company's active status in regulatory records.
16
